<DOC>
	<DOC>NCT01538108</DOC>
	<brief_summary>The purpose of this study is to demonstrate the safety and effectiveness of the use of NMB's percutaneous transluminal angioplasty (PTA) Balloon.</brief_summary>
	<brief_title>Study of NMB (Company's Name) Drug Ejecting Balloon for Arteriovenous Fistulae</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>patients 18 years and older Patients with arteriovenous fistula with obstructive lesion Patient who is willing and able to sign a written informed consent age &lt; 18 female with child bearing potential Previous participation in another study with any investigational drug or device within the past 30 days Life expectancy of less than 12 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>